3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
9
Head & Neck
1
CNS
1
Conditions
Squamous Cell Carcinoma of Head and Neck
123
Head and Neck Neoplasms
80
Oropharyngeal Neoplasms
19
Carcinoma, Non-Small-Cell Lung
15
Laryngeal Neoplasms
13
Carcinoma, Squamous Cell
13
Salivary Gland Neoplasms
12
Carcinoma
12
Mouth Neoplasms
11
Ovarian Neoplasms
9
Neoplasm Metastasis
9
Nasopharyngeal Carcinoma
9
Nasopharyngeal Neoplasms
8
Esophageal Neoplasms
8
Stomach Neoplasms
7
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Lung Neoplasms
6
Hypopharyngeal Neoplasms
6
Colorectal Neoplasms
6
Uterine Cervical Neoplasms
5
Small Cell Lung Carcinoma
5
Recurrence
5
Papillomavirus Infections
5
Melanoma
5
Breast Neoplasms
5
Urinary Bladder Neoplasms
4
Tongue Neoplasms
4
Sarcoma
4
Pancreatic Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Interventions
selpercatinib
2
pralsetinib
2
repotrectinib
1
pembrolizumab
1
alectinib
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Respiratory Tract Diseases
×
Carboplatin
×
Head & Neck
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts